Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of June 30, 2018, December 31, 2017, June 30, 2017 and December 31, 2016.

 

(Dollars in thousands)   June 30, 2018     December 31, 2017     June 30, 2017     December 31, 2016  
Cash and cash equivalents   $ 8,903     $ 7,307     $ 11,266     $ 4,105  
                                 
Restricted cash included in current/long term assets     636       691       692       692  
                                 
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 9,539     $ 7,998     $ 11,958     $ 4,797  

Schedule of Antidilutive Securities

The following schedule details the number of shares issuable upon the exercise of stock options, warrants and conversion of preferred stock, which have been excluded from the diluted loss per share calculation as the inclusion would be anti-dilutive for the six months ended June 30, 2018 and 2017:

 

    Three month period
Ended June 30, 		    Six month period
Ended June 30, 		 
    2018     2017     2018     2017  
Stock options     12,133       11,026       12,133       11,026  
                                 
Preferred Stock issuable upon conversion     30,628       15,240       30,628       15,240  
                                 
Warrants     6,198       5,961       6,198       5,961  
                                 
Total     48,959       32,227       48,959       32,227